Mibampator (LY451395) Randomized Clinical Trial for Agitation/Aggression in Alzheimer’s disease

BACKGROUND: Mibampator, an AMPA receptor potentiator, was evaluated for treatment of agitation and aggression (A/A) in Alzheimer’s disease (AD). METHODS: Outpatients (n=132) with probable AD and A/A randomized to 12 weeks of double-blind treatment with 3 mg po mibampator or placebo were assessed usi...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Trzepacz, Paula T., Cummings, Jeffrey, Konechnik, Thomas, Forrester, Tammy D., Chang, Curtis, Dennehy, Ellen B., Willis, Brian A., Shuler, Catherine, Tabas, Linda B, Lyketsos, Constantine
Format: Artigo
Idioma:Inglês
Publicat: 2012
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3938603/
https://ncbi.nlm.nih.gov/pubmed/23257314
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1017/S1041610212002141
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars